Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Legood

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Journal of Advanced Nursing|April 7, 2005
Pressure ulcers: guideline development and economic modellingRosa Legood, Elizabeth McInnes
Oncotarget|September 22, 2018
Population based germline testing for primary cancer preventionRanjit Manchanda, Rosa Legood
Preventive Medicine|June 9, 2020
Cost-effectiveness evidence for HPV self-sampling could be improved by giving greater attention to vulnerable populationsEmily Humphreys, Anna Foss, Rosa Legood
Health Policy (Amsterdam, Netherlands)|July 16, 2008
From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gapRosa Legood, Jane Wolstenholme, Alastair Gray
AIDS (London, England)|June 15, 2010
Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settingsEugene Athan, Daniel P O'Brien, Rosa Legood
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 4, 2009
Calibration of disease simulation model using an engineering approachTazio Vanni, Rosa Legood, Richard G White
Health Economics|January 19, 2016
Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?Ulla Kou Griffiths, Rosa Legood, Catherine Pitt
Gynecologic Oncology|October 6, 2015
Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal womenRanjit Manchanda, Rosa Legood, Leigh Pearce, et al.
BMJ (Clinical Research Ed.)|January 10, 2006
Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studiesRosa Legood, Alastair Gray, Jane Wolstenholme, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 30, 2007
Eliciting expert opinion for economic models: an applied exampleJosé Leal, Sarah Wordsworth, Rosa Legood, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Journal of Advanced Nursing|April 7, 2005
Pressure ulcers: guideline development and economic modellingRosa Legood, Elizabeth McInnes
Oncotarget|September 22, 2018
Population based germline testing for primary cancer preventionRanjit Manchanda, Rosa Legood
Preventive Medicine|June 9, 2020
Cost-effectiveness evidence for HPV self-sampling could be improved by giving greater attention to vulnerable populationsEmily Humphreys, Anna Foss, Rosa Legood
Health Policy (Amsterdam, Netherlands)|July 16, 2008
From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gapRosa Legood, Jane Wolstenholme, Alastair Gray
AIDS (London, England)|June 15, 2010
Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settingsEugene Athan, Daniel P O'Brien, Rosa Legood
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 4, 2009
Calibration of disease simulation model using an engineering approachTazio Vanni, Rosa Legood, Richard G White
Health Economics|January 19, 2016
Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?Ulla Kou Griffiths, Rosa Legood, Catherine Pitt
Gynecologic Oncology|October 6, 2015
Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal womenRanjit Manchanda, Rosa Legood, Leigh Pearce, et al.
BMJ (Clinical Research Ed.)|January 10, 2006
Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studiesRosa Legood, Alastair Gray, Jane Wolstenholme, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 30, 2007
Eliciting expert opinion for economic models: an applied exampleJosé Leal, Sarah Wordsworth, Rosa Legood, et al.
Pageof 9